Delivery Order SPE2DB22D7058-SPE2DB25FSWC8
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,778.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 50 MG VIALS, a medical product, and has a completion date of February 12, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of ACTIVASE 50MG INJ 1S medical supplies. The contract has a ceiling value of $40,707.66 and runs through October 21, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, with a ceiling value of $24,939.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 100 MG VIALS, a specialized pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award, valued at $19,953.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560956486 ACTIVASE 100 MG VIALS, a medical product used in healthcare. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 17, 2023. This award is not associated with a set-aside...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ACTIVASE 100 MG VIALS medical products. The contract has a ceiling value of $11,427.70 and is structured as a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,699.37 firm fixed-price delivery order is for the supply of ACTIVASE 50 MG VIALS, with a period of performance extending through March 6, 2025. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,864.71 contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, to support the DLA's Medical Supply Chain program. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2024. This appears to be a delivery order under...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of ACTIVASE 50MG INJ 1S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $11,016.14 and a performance period through July 2, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,266.89 firm fixed price delivery order is for the supply of 4,568,373,042 units of ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp is a for-profit company that serves as a critical supplier of medical and pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,290.62, is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of ACTIVASE 50 MG VIALS, a critical medical commodity. This contract...